 | Gain Therapeutics, Inc. | |||
| NGM : GANX || Location: United States | ||||
$3.07-0.12 (-3.76%) |
0.14 M | 2.95 - 3.2 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.150 M |
| March 28, 2024 | 0.138 M |
| March 15, 2024 | 0.157 M |
| Feb. 29, 2024 | 0.135 M |
| Feb. 15, 2024 | 0.138 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.33 | -0.36 | -9.42% |
| 09/30/2023 | -0.45 | -0.37 | 18.66% |
| 06/30/2023 | -0.31 | -0.62 | -97.64% |
| 03/31/2023 | -0.40 | -0.43 | -7.18% |
| 12/31/2022 | -0.39 | -0.39 | -1.27% |
GANX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 16.220M | Shares Float | 14.263M |
| Short Float | 0.150M | Market Cap | 51.74M |
| Institution ownership | 11.79% | Insider ownership | 16.451% |
| Earnings Date | 05/08/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.71 | Forward EPS | -1.18 |